Studies indicate that ER-negative breast cancer cells seems to have extensive deregulations in their estrogen receptor pathway since restored ER expression in ER-negative breast cancer cells did not restore the ability of estrogen to stimulate proliferation [27]. Here, ESR1 is linked to breast carcinoma.